Related Experiment Video
Updated: Jan 14, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
RhD-negative red blood cell use and conservation strategies in the Region of Southern Denmark
Emil Ainsworth Jochumsen1, Kjell E Titlestad1, Ulrik Sprogøe1
1Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Background And Objectives:
Suboptimal use of RhD-negative red blood cells (RBCs) can lead to reduced inventories of this scarce resource. Prevention of D-alloimmunization is particularly important for RhD-negative females of childbearing potential (FCPs). The utilization of RBCs in the Region of Southern Denmark was analysed to elucidate opportunities for conserving RhD-negative RBCs.
Materials And Methods:
RBC transfusions from 1 January 2020 to 31 December 2024 were identified using the South Danish Transfusion Service's laboratory and inventory IT systems. RhD-typing results, including the time when the patient's RhD type became known, were used to identify whether a historical or current RhD type was available at the time of RBC transfusion. Transfusions were grouped into 72-h 'transfusion episodes', and the achievement of the RBC critical administration threshold (CAT; 3 RBC units/h) was noted.
Results:
There were 30,564 recipients of 162,778 RBC units. Of these units, 36,483 (22%) units were RhD-negative, out of which 22,922 (63%) were crossmatched (i.e., sufficient time was available to demonstrate compatibility with recipient plasma) and issued to RhD-negative non-FCPs; 1934 (5%) units were uncrossmatched and urgently transfused to 1409 patients who were historically known to be RhD-positive, and 934 (3%) units were transfused to 303 non-FCPs without a current or historical RhD type. In RhD-negative patients who reached CAT, 1440 of 36,483 (4%) RhD-negative RBC units were transfused after they had reached CAT.
Conclusion:
Many of the RhD-negative RBC units were issued to recipients who were not RhD-negative FCPs, those known to be RhD-positive and those requiring massive transfusion, suggesting strategies for resource conservation.
More Related Videos
11:31Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
Published on: January 2, 2013
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Rh Blood Group
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...